Supportive Care

Adelaide, Australia—Nausea is part of a symptom cluster associated with chemotherapy, but the experience of nausea may be a symptom cluster in and of itself, according to a study presented by Ian Olver, MD, President of the Multinational Association of Supportive Care in Cancer (MASCC), Director of the Sansom Institute for Health Research, and Professor of Translational Cancer Research, University of South Australia, Adelaide, at the 2016 MASCC/International Society of Oral Oncology Annual Meeting on Supportive Care in Cancer.

“Magic Mouthwash” for mTOR Inhibitor–Associated Stomatitis?

Meg Barbor, MPH

Adelaide, Australia—Stomatitis is a dose-limiting toxicity associated with the use of mammalian target of rapamycin (mTOR) inhibitors, but new treatments can improve quality of life for patients suffering from this often debilitating condition, according to data presented at the 2016 Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology Annual Meeting on Supportive Care in Cancer.

Multivitamin Use During Chemotherapy May Reduce Risk for Peripheral Neuropathy

Caroline Helwick

Multivitamin supplement use was associated with a reduction in symptoms of chemotherapy-induced peripheral neuropathy (CIPN) in a subanalysis of the SWOG S0221 trial. Patients who were using multivitamins before chemotherapy had 40% less neuropathy, and those using them during or after treatment had a 23% reduced risk.

Aspergillus and the Azoles in 2015

Meg Barbor, MPH

Austin, TX-Three advanced azole agents are now being used to treat invasive aspergillosis, and strengths and weaknesses exist for each of them, according to research presented by James S. Lewis II, PharmD, at the 11th annual Hematology/Oncology Pharmacy Association conference.

The Perceptual Gap in the Impact of Chemotherapy- and Radiotherapy-Induced Nausea and Vomiting

Meg Barbor, MPH

The severity and impact of nausea and vomiting (NV) on patients undergoing chemotherapy and radiotherapy is greater than estimated by oncology physicians and nurses, according to research presented by Cheryl Vidall at the 2015 Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology Annual Meeting on Supportive Care in Cancer.

Opioid-Induced Constipation

Amanda R. McFee Winans, PharmD, BCPS; Jayne Pawasauskas, PharmD, BCPS; Leah Sera, PharmD, BCPS

This section provides a quick update of symptomatic conditions in oncology and their management. Readers are invited to submit brief updates following the guidelines provided within.

The Role of the Oncology Nurse Navigator in Improving Supportive Care

Barbara Rogers, CRNP, MN, AOCN, ANP-BC

A nurse/patient navigator is defined by the Academy of Oncology Nurse & Patient Navigators as “a medical professional whose clinical expertise and training guides patients and their caregivers to make informed decisions, collaborating with a multidisciplinary team to allow for timely cancer screening, diagnosis, treatment, and increased supportive care across the cancer continuum.”

Colorectal Cancer Survivors Frequently Report Bowel Dysfunction

Chase Doyle

According to a recent assessment of bowel dysfunction–related needs, the hardships for colorectal cancer (CRC) survivors continue long after leaving the operating room, and survivors desire more information and strategies to help cope with unexpected changes to their bowel patterns, researchers said at the 2015 Gastrointestinal Cancers Symposium held in San Francisco, CA.

Symptom Management Drives Value in Oncology

Chase Doyle

Novel Agent Effective for the Management of Cancer-Related Cachexia

Phoebe Starr

Cancer-related cachexia is a debilitating condition that has had no effective treatment thus far. Its symptoms include loss of lean body mass, as well as muscle wasting and loss of appetite.

Page 2 of 8
Results 11 - 20 of 74

Supportive Care

I'd like to receive: